CD Biosynsis offers specialized Vibrio natriegens CRISPR Interference (CRISPRi) Gene Repression Services to facilitate high-throughput metabolic engineering in this ultra-fast-growing microbial host. V. natriegens is an attractive chassis for industrial biotechnology dueing to its rapid doubling time (approximately 10 min) and high respiratory capacity. The CRISPRi system, utilizing a deactivated Cas9 (dCas9) and a guide RNA (gRNA), provides precise, tunable, and reversible gene repression without permanently altering the genome. Our services leverage this technology for metabolic pathway balancing, reducing flux to competing pathways, and fine-tuning gene expression levels crucial for maximizing product yield. We provide integrated services from target design and gRNA synthesis to final strain characterization, enabling predictable and efficient strain optimization in this non-model organism.
Get a QuoteThe rapid growth rate of Vibrio natriegens requires extremely fast and precise genetic tools to manage its complex, dual-chromosome metabolism. Unlike traditional knockout methods, CRISPRi allows us to implement gene knockdown (partial repression) which is often superior for essential genes or for balancing the flux between multiple pathways. This is critical for optimizing the production of valuable chemicals where precise control over enzyme levels is necessary. Our services are tailored to address the challenges specific to this host, providing reliable, quantitative control over gene expression levels necessary for high-speed biomanufacturing cycles.
Rational gRNA Design
Computational design of single guide RNAs (gRNAs) targeting promoter regions or the initial coding sequence to achieve maximal transcriptional repression.
gRNA Library Construction
High-diversity library generation (e.g., 5-10 gRNAs per target gene) to screen for the optimal repression level, or parallel screening of multiple genes.
Off-Target Minimization
Bioinformatics screening to ensure gRNAs exhibit high specificity for the target gene while minimizing potential off-target binding on both V. natriegens chromosomes.
dCas9 Expression
Integration of dCas9 (deactivated Cas9) gene, often chromosomally, under the control of a constitutive or inducible promoter for basal control.
Inducible Repression
Use of inducible promoters (e.g., arabinose or rhamnose systems) to control dCas9 expression, allowing for precise, time-dependent repression during fermentation.
Multiplexing Capability
Design of polycistronic gRNA expression cassettes (e.g., using RNA processing systems) to simultaneously repress multiple genes within a single strain.
Pathway Flux Balancing
Precisely reducing the expression of native metabolic enzymes that compete with the engineered pathway for carbon or energy precursors.
Repression of Essential Genes
Using partial repression (knockdown) to tune the expression of essential genes (e.g., TCA cycle) to redirect flux while maintaining cell viability and growth.
High-Throughput Screening
Implementation of CRISPRi libraries for rapid, parallel screening of hundreds of different gene repression targets to identify the most effective optimization strategy.
A systematic process from target identification to validated repressed strain.
1. Target Identification & Design
2. CRISPRi System Construction
3. Repression & Screening
4. Validation & Delivery
Bioinformatics analysis to identify competing pathways or undesirable byproducts in V. natriegens.
In-silico gRNA design, ensuring minimal off-target effects and optimal placement for dCas9 binding.
Design of inducible dCas9 or gRNA expression cassettes.
Construction of the dCas9 expression cassette (often integrated chromosomally for stability).
Cloning of designed gRNA(s) into the expression vector/cassette.
Transformation/conjugation of the complete CRISPRi system into the V. natriegens host.
Verification of gene repression level via qPCR or Western Blot.
Final metabolic flux analysis (optional) to confirm intended redirection of carbon flow.
Delivery of the optimized, stably repressed V. natriegens strain and full data report.
Ultra-Host Specific Expertise
Extensive experience working with the non-model, dual-chromosome system of V. natriegens, ensuring robust and stable CRISPRi performance.
Tunable Gene Expression
Unlike permanent knockouts, CRISPRi allows for precise, graded repression of a gene, enabling optimal metabolic balancing required for complex pathway engineering.
Multiplex Repression
Capability to simultaneously repress multiple target genes using a single dCas9 system and polycistronic gRNAs, accelerating complex pathway optimization.
Time-Saving Reversibility
The repression is reversible by removing the inducer, which is critical for rapidly testing various optimization strategies without requiring new, permanent genetic modifications.
1. Why choose CRISPRi repression over a gene knockout for metabolic engineering?
CRISPRi provides tunable repression (knockdown), which is essential for genes that are necessary for growth or cell viability. A full knockout of an essential gene would be lethal, while CRISPRi allows for partial repression to redirect flux while keeping the cell alive and growing.
2. How quickly can the repression effect be reversed?
The repression is rapidly reversible. By removing the inducer molecule (if an inducible system is used) or stopping gRNA expression, dCas9 unbinds from the DNA, allowing transcription to resume quickly, often within one or two growth cycles.
3. Can CRISPRi be used to repress genes on both of V. natriegens's chromosomes?
Yes. The gRNAs are designed to target specific sequences on either Chromosome I or Chromosome II, allowing us to control gene expression across the entire dual-chromosome genome.
4. Is the CRISPRi system integrated into the V. natriegens genome?
We offer both plasmid-based and chromosomal integration of the dCas9 component. For maximum stability and consistent results across high-speed fermentations, chromosomal integration of dCas9 is often recommended.
5. How do you ensure the gRNAs only target the desired gene?
We use sophisticated bioinformatics tools to screen gRNA candidates against the entire V. natriegens genome (both Chromosome I and II) to eliminate sequences with potential off-target binding sites, ensuring high specificity.
6. What level of gene repression can I expect using CRISPRi?
Depending on the gRNA binding site and design, repression levels typically range from 70% to over 95%. By using a library of different gRNAs, we can screen for the precise knockdown percentage that results in optimal product yield.
7. Can this service be combined with traditional gene editing?
Absolutely. CRISPRi is often used as a preliminary screening tool to identify the most critical repression targets before proceeding with permanent, optimized genomic edits (knockouts or promoter tuning) using CRISPR-Cas9 or Base Editing.
8. Does V. natriegens's rapid growth affect the CRISPRi stability?
To ensure stability during rapid growth, we primarily use highly stable, low-copy-number plasmids or, preferably, chromosomal integration for the dCas9 expression cassette, minimizing the risk of component loss during high-speed cell division.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.